Global Bioinformatics Market All Set to Register a CAGR of 21.2% According to The Newly Added Report at Analyze Future

• 

Rising integrated data need, demand for drug development and discovery, greater focus in genomics & proteomics, and encouraging government policies are propelling the growth of market.

Portland, Oregon (PRWEB UK) 3 June 2014

Analyze Future publishes a latest report titled "Bioinformatics Market - Global Industry Analysis, Size, Growth Trends, Share, Opportunities and Forecast."

The study suggest that the global Bioinformatics market would touch a figure of $12.8 billion by 2020, registering a CAGR of 21.2% during 2014-2020.

To view complete report, visit http://www.analyzefuture.com/bioinformatics-market.

Bioinformatics refers to a system that manages biological data. Development of bioinformatics would prove to be beneficial in numerous fields such as drug discovery and development, molecular medicine, gene therapy, personalized medicines, preventive medicines, etc.

Rising integrated data need, demand for drug development and discovery, greater focus in genomics & proteomics, and encouraging government policies are propelling the growth of market. The limitations for the growth of this market are the need for skilled personnel, saturation of the pharmaceutical sector and lack of common data formats.

The report segments the bioinformatics technology and services market into knowledge management tools, bioinformatics platforms and bioinformatics services. Due to higher use of bioinformatics tools in various genomic studies, it generated maximum revenue in the year 2013. However, the report expects the knowledge management tools to generate maximum revenue by 2020. This can be credited to the rising data integration need, increase in clinical trials and growth in the proteomic data.

Browse related report

Global stem cell umbilical cord blood (UCB) market: Umbilical cord blood stem cells are potential stem cells that can convert into any type of -determined cells. Global stem cell market is dominating the healthcare industry with its reliable and cost effective method of treatment with fewer side effects. Current market for cord blood therapeutics accounts for $6.5 billion, which is expected to grow at 33.4% CAGR from 2013-2020. Other segments of this market include adult stem cell and embryonic stem cells. Government authorities are supporting the research and clinical trials of cord blood stem cell, which is currently increasing the interest of healthcare companies to invest in research and commercialization of cord blood stem cell therapies.

See the stem cell umbilical cord blood (UCB) market report at http://www.analyzefuture.com/stem-cell-umbilical-cord-blood-UCB-market.

Global flow cytometry market: Flow cytometry measures and analyzes cells of various characterizations through a light beam that is passed through a suspension of fluid. Several properties of the cell structure and functions can be studied with the help of this technique. Flow cytometry market was valued $3000 million in 2012, and is expected to reach a value of $6530 million by 2020, experiencing a CAGR of 30.9%.

See the flow cytometry market report at http://www.analyzefuture.com/flow-cytometry-market.

Global in vitro diagnostics (IVD) market: In-Vitro Diagnostics (IVD) provides critical information about the physiological and pathological state of body for effective health and drug/therapy monitoring. Global In-Vitro diagnosis market was valued at $49.3 billion 2012 and is estimated to grow at a CAGR of 7.5% during 2012-2020. Increasing ageing population and rising cases of infectious diseases and chronic diseases such as cardiovascular diseases, diabetes, cancer, and sexually transmitted diseases are significant growth drivers of this market.

See the in vitro diagnostics (IVD) market report at http://www.analyzefuture.com/in-vitro-diagnostic-ivd-market.

Global respiratory syncytial virus (RSV) diagnostic market: Respiratory syncytial virus (RSV) is a virus which causes respiratory infections such as bronchiolitis and pneumonia. Globally, the cases of RSV infections are on the rise which is fueling the demand for rapid diagnostic techniques. According to the CDC, each year, on an average, RSV leads to the hospitalization of around 1,32,000- 172,000 children below the age of five and the death of around 14,000 adults above the age of 65 in the United States alone. This rising incidence of RSV infections is the major driving force for this market.

See the respiratory syncytial virus (RSV) diagnostic market report at http://www.analyzefuture.com/respiratory-syncytial-virus-RSV-diagnostic-market.

Global synthetic biology market: Synthetic biology is a novel field that finds its origin at the intersection of biology and engineering. It involves designing and construction of biological systems or devices that can be applied in varied domains to get specified results. It’s a multidisciplinary effort made by scientists to understand the functioning of biological organisms, cells & genes and implementation of artificial genetic processes to give specific characteristics to an organism. It can even be used to develop a completely new biological system. Global synthetic biology market was valued at $3.0 billion in 2013 and it is estimated to reach $38.7 billion by 2020, growing at a CAGR of 44.2% during the forecast period.

See the synthetic biology market report at http://www.analyzefuture.com/synthetic-biology-market.

The report segments the bioinformatics market on the basis of applications, namely metabolomics, molecular phylogenetics, transcriptomics, proteomics, chemoinformatics, genomics and others. The genomic application segment was estimated to be the major revenue generating segment in 2013; however, by 2020, chemoinformatics would supersede genomic.

The report segments the bioinformatics sector market into medical bioinformatics, animal bioinformatics, agriculture bioinformatics, academics and others. The report forecasts that medical bioinformatics would continue to remain the maximum revenue generating segment till 2020. The academics sector is expected to grow at a CAGR of 38.5% during 2014-2020.

North America remains the highest revenue generating region due to widespread application of bioinformatics, whereas, Asia Pacific region would grow fastest due to governments initiatives.

Some of the key profiled firms in the field of bioinformatics are:
Accelrys Inc.
Affymetrix Inc.
Agilent technologies, Inc.
Geneva bioinformatics
Non linear dynamics
Quest Diagnostics, Inc.
Life Technologies corp
Illumina, BrukerDaltonics, inc.
Biomax informatics AG

Browse all diagnostic and biotech market report at http://www.analyzefuture.com/diagnostic-and-biotech-market-report.

About Us:

We bring to you research reports that will help you take an informed and strategic oriented decisions. Our sourced research reports are highly authentic and integrate latest market development for a better understanding. We have a repository of large market research reports helping with different needs.

We have research reports for numerous sectors and this is one place where you can find answers to your market research queries. We have tie up with repute market publisher who provide high quality and precise reports. You can rely on such information and definitely find it relevant.

We have a very efficient team who understands your queries and answers them promptly. They are well versed with all the market updated and latest trends and can guide you with purchase of reports.

Analyze future sells your most ethical and integrated market research reports at best price.

Contact:
Sona Padman
5320 SW Macadam Avenue,
Suite 100, Portland, OR 97239
United States
Direct: +1(617)674-4143
Toll Free: +1(855)711-1555 (U.S. & Canada)
Fax: +1(855)550-5975
Email: sales(at)analyzefuture(dot)com
Blog: http://analyzefuture.blogspot.com

PDF Print